Identification of a Common Gene Expression Signature in Dilated Cardiomyopathy Across Independent Microarray Studies

Andreas S. Barth, Ruprecht Kuner, Andreas Buness, Markus Ruschhaupt, Sylvia Merk, Ludwig Zwermann, Stefan Kääb, Eckart Kreuzer, Gerhard Steinbeck, Ulrich Mansmann, Annemarie Poustka, Michael Nabauer, Holger Sültmann

Research output: Contribution to journalArticlepeer-review

Abstract

Objectives: This study was designed to identify a common gene expression signature in dilated cardiomyopathy (DCM) across different microarray studies. Background: Dilated cardiomyopathy is a common cause of heart failure in Western countries. Although gene expression arrays have emerged as a powerful tool for delineating complex disease patterns, differences in platform technology, tissue heterogeneity, and small sample sizes obscure the underlying pathophysiologic events and hamper a comprehensive interpretation of different microarray studies in heart failure. Methods: We accounted for tissue heterogeneity and technical aspects by performing 2 genome-wide expression studies based on cDNA and short-oligonucleotide microarray platforms which comprised independent septal and left ventricular tissue samples from nonfailing (NF) (n = 20) and DCM (n = 20) hearts. Results: Concordant results emerged for major gene ontology classes between cDNA and oligonucleotide microarrays. Notably, immune response processes displayed the most pronounced down-regulation on both microarray types, linking this functional gene class to the pathogenesis of end-stage DCM. Furthermore, a robust set of 27 genes was identified that classified DCM and NF samples with >90% accuracy in a total of 108 myocardial samples from our cDNA and oligonucleotide microarray studies as well as 2 publicly available datasets. Conclusions: For the first time, independent microarray datasets pointed to significant involvement of immune response processes in end-stage DCM. Moreover, based on 4 independent microarray datasets, we present a robust gene expression signature of DCM, encouraging future prospective studies for the implementation of disease biomarkers in the management of patients with heart failure.

Original languageEnglish (US)
Pages (from-to)1610-1617
Number of pages8
JournalJournal of the American College of Cardiology
Volume48
Issue number8
DOIs
StatePublished - Oct 17 2006
Externally publishedYes

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Identification of a Common Gene Expression Signature in Dilated Cardiomyopathy Across Independent Microarray Studies'. Together they form a unique fingerprint.

Cite this